201 related articles for article (PubMed ID: 25130613)
1. Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.
Koro C; Bielecka E; Dahl-Knudsen A; Enghild JJ; Scavenius C; Brun JG; Binder V; Hellvard A; Bergum B; Jonsson R; Potempa J; Blom AM; Mydel P
Eur J Immunol; 2014 Nov; 44(11):3403-12. PubMed ID: 25130613
[TBL] [Abstract][Full Text] [Related]
2. Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
Lubbers R; Oostindie SC; Dijkstra DJ; Parren PWHI; Verheul MK; Abendstein L; Sharp TH; de Ru A; Janssen GMC; van Veelen PA; van den Bremer ETJ; Bleijlevens B; de Kreuk BJ; Beurskens FJ; Trouw LA
Clin Exp Immunol; 2020 Apr; 200(1):1-11. PubMed ID: 31853959
[TBL] [Abstract][Full Text] [Related]
3. Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation.
van den Bremer ET; Beurskens FJ; Voorhorst M; Engelberts PJ; de Jong RN; van der Boom BG; Cook EM; Lindorfer MA; Taylor RP; van Berkel PH; Parren PW
MAbs; 2015; 7(4):672-80. PubMed ID: 26037225
[TBL] [Abstract][Full Text] [Related]
4. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
5. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
Thommesen JE; Michaelsen TE; Løset GÅ; Sandlie I; Brekke OH
Mol Immunol; 2000 Nov; 37(16):995-1004. PubMed ID: 11395138
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc.
Idusogie EE; Presta LG; Gazzano-Santoro H; Totpal K; Wong PY; Ultsch M; Meng YG; Mulkerrin MG
J Immunol; 2000 Apr; 164(8):4178-84. PubMed ID: 10754313
[TBL] [Abstract][Full Text] [Related]
8. Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding.
Kline JB; Fernando S; Ross EN; Grasso L; Nicolaides NC
Eur J Immunol; 2018 Nov; 48(11):1872-1882. PubMed ID: 30144039
[TBL] [Abstract][Full Text] [Related]
9. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
[TBL] [Abstract][Full Text] [Related]
10. Carbamylated LL-37 as a modulator of the immune response.
Koro C; Hellvard A; Delaleu N; Binder V; Scavenius C; Bergum B; Główczyk I; Roberts HM; Chapple IL; Grant MM; Rapala-Kozik M; Klaga K; Enghild JJ; Potempa J; Mydel P
Innate Immun; 2016 Apr; 22(3):218-29. PubMed ID: 26878866
[TBL] [Abstract][Full Text] [Related]
11. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q.
Vogt LM; Kwasniewicz E; Talens S; Scavenius C; Bielecka E; Ekdahl KN; Enghild JJ; Mörgelin M; Saxne T; Potempa J; Blom AM
J Immunol; 2020 May; 204(10):2779-2790. PubMed ID: 32253242
[TBL] [Abstract][Full Text] [Related]
13. Engineered antibodies with increased activity to recruit complement.
Idusogie EE; Wong PY; Presta LG; Gazzano-Santoro H; Totpal K; Ultsch M; Mulkerrin MG
J Immunol; 2001 Feb; 166(4):2571-5. PubMed ID: 11160318
[TBL] [Abstract][Full Text] [Related]
14. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
Redpath S; Michaelsen T; Sandlie I; Clark MR
Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
16. Complement activation impacts B-cell depletion by both type I and type II CD20 monoclonal antibodies.
Beurskens FJ; Ruuls SR; Engelberts PJ; Vink T; Mackus WJ; van de Winkel JG; Parren PW
Blood; 2008 Nov; 112(10):4354-5; author reply 4355-6. PubMed ID: 18988880
[No Abstract] [Full Text] [Related]
17. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.
Lilienthal GM; Rahmöller J; Petry J; Bartsch YC; Leliavski A; Ehlers M
Front Immunol; 2018; 9():958. PubMed ID: 29867943
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques?
Delporte C; Zouaoui Boudjeltia K; Furtmüller PG; Maki RA; Dieu M; Noyon C; Soudi M; Dufour D; Coremans C; Nuyens V; Reye F; Rousseau A; Raes M; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Robaye B; Vanhamme L; Reynolds WF; Obinger C; Van Antwerpen P
J Biol Chem; 2018 Apr; 293(17):6374-6386. PubMed ID: 29496995
[TBL] [Abstract][Full Text] [Related]
19. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
Tan LA; Yang AC; Kishore U; Sim RB
Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
[TBL] [Abstract][Full Text] [Related]
20. Pitfalls in the detection of citrullination and carbamylation.
Verheul MK; van Veelen PA; van Delft MAM; de Ru A; Janssen GMC; Rispens T; Toes REM; Trouw LA
Autoimmun Rev; 2018 Feb; 17(2):136-141. PubMed ID: 29203292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
